<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckley, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Braunwald, Eugene</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Treatment of AMI in the Post-Herrick Era</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012-05-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">6-7</style></pages><abstract><style  face="normal" font="default" size="100%">This article delves into the early gains that were made in the treatment of AMI, noting that the field has changed dramatically since 1912, when James B. Herrick, MD, postulated that thrombosis in the coronary artery leads to the symptoms and abnormalities that are associated with heart attacks [Herrick JB. JAMA 1912]. It further covers the major advances over the subsequent 100 years and provided a vision for cardiovascular medicine in the coming century.</style></abstract><number><style face="normal" font="default" size="100%">4</style></number><volume><style face="normal" font="default" size="100%">12</style></volume></record></records></xml>